NEON THERAPEUTICS INC - COM (NTGN)

CUSIP: 64050Y100

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COM
Total 13F shares
16,486,203
Share change
-2,157,916
Total reported value
$28,357,032
Price per share
$1.72
Number of holders
56
Value change
-$13,282,649
Number of buys
35
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 64050Y100?
CUSIP 64050Y100 identifies NTGN - NEON THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEON THERAPEUTICS INC - COM (NTGN) as of Q3 2019

As of 30 Sep 2019, NEON THERAPEUTICS INC - COM (NTGN) was held by 56 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,486,203 shares. The largest 10 holders included TRV GP III, LLC, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, HARVARD MANAGEMENT CO INC, STATE STREET CORP, FNY Investment Advisers, LLC, OXFORD ASSET MANAGEMENT LLP, Endurant Capital Management LP, and NORTHERN TRUST CORP. This page lists 56 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.